We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.41%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$18.5B
AUM Growth
+$2.73B
(+17%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
6.38%
Top 10 Holdings %
Top 10 Hldgs %
17.08%
Holding
1,449
New
438
Increased
447
Reduced
240
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$224M |
| 2 |
Boeing
BA
|
+$182M |
| 3 |
Bank of America
BAC
|
+$178M |
| 4 |
Citigroup
C
|
+$126M |
| 5 |
JPMorgan Chase
JPM
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$363M |
| 2 |
BP
BP
|
+$245M |
| 3 |
GSK
GSK
|
+$165M |
| 4 |
Nokia
NOK
|
+$142M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.33% |
| 2 | Technology | 18.71% |
| 3 | Healthcare | 16.5% |
| 4 | Communication Services | 12.26% |
| 5 | Industrials | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZVO
726
DELISTED
Zovio Inc. Common Stock
ZVO
| $1.56M | 0.01% |
+88,334
| New | +$1.6M |
|
|
WBMD
727
DELISTED
WebMD Health Corp.
WBMD
| $1.55M | 0.01% |
39,335
-215,695
| -85% | -$7.78M |
|
|
IGTE
728
DELISTED
IGATE CORPORATION
IGTE
| $1.55M | 0.01% |
38,671
+31,504
| +440% | +$1.05M |
|
|
NEWP
729
DELISTED
NEWPORT CORP
NEWP
| $1.54M | 0.01% |
+85,013
| New | +$1.39M |
|
730
MSCI
MSCI
$40.9B
| $1.53M | 0.01% |
+35,108
| New | +$1.48M |
|
731
Cracker Barrel
CBRL
$1.29B
| $1.53M | 0.01% |
+13,902
| New | +$1.51M |
|
732
FTI Consulting
FCN
$4.18B
| $1.52M | 0.01% |
+37,062
| New | +$1.54M |
|
|
FMBI
733
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1.52M | 0.01% |
86,972
+49,523
| +132% | +$837K |
|
734
AngioDynamics
ANGO
$649M
| $1.52M | 0.01% |
+88,305
| New | +$1.36M |
|
735
Dorman Products
DORM
$4.18B
| $1.51M | 0.01% |
+27,002
| New | +$1.36M |
|
|
CVSA
736
Covista Inc
CVSA
$4.8B
| $1.51M | 0.01% |
+42,569
| New | +$1.47M |
|
|
PHH
737
DELISTED
PHH Corporation
PHH
| $1.51M | 0.01% |
+61,953
| New | +$1.49M |
|
|
CBL
738
DELISTED
CBL& Associates Properties, Inc.
CBL
| $1.51M | 0.01% |
+83,985
| New | +$1.58M |
|
|
FBRC
739
DELISTED
FBR & Co. Common Stock
FBRC
| $1.49M | 0.01% |
56,550
+17,368
| +44% | +$467K |
|
|
CMD
740
DELISTED
Cantel Medical Corporation
CMD
| $1.48M | 0.01% |
+43,743
| New | +$1.52M |
|
|
SGNT
741
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.48M | 0.01% |
58,193
+4,113
| +8% | +$92.9K |
|
742
Rambus
RMBS
$11B
| $1.47M | 0.01% |
155,632
-2,411
| -2% | -$21.7K |
|
743
Euronet Worldwide
EEFT
$2.7B
| $1.47M | 0.01% |
+30,723
| New | +$1.38M |
|
744
Sturm, Ruger & Co
RGR
$593M
| $1.47M | 0.01% |
20,073
-25,384
| -56% | -$1.79M |
|
745
SS&C Technologies
SSNC
$18.6B
| $1.46M | 0.01% |
+66,104
| New | +$1.33M |
|
|
ANW
746
DELISTED
Aegean Marine Petroleum Network
ANW
| $1.46M | 0.01% |
+130,244
| New | +$1.4M |
|
747
Adeia
ADEA
$3.11B
| $1.46M | 0.01% |
278,960
+84,906
| +44% | +$432K |
|
748
Extreme Networks
EXTR
$3.15B
| $1.43M | 0.01% |
204,877
-128,937
| -39% | -$801K |
|
|
SNV
749
DELISTED
Synovus
SNV
| $1.43M | 0.01% |
56,860
+2,581
| +5% | +$60.8K |
|
|
NTT
750
DELISTED
Nippon Telegraph & Telephone
NTT
| $1.43M | 0.01% |
52,948
-225,746
| -81% | -$5.93M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Arrowstreet Capital held 1,449 positions worth $18.5B, up 17% from $15.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Arrowstreet Capital deployed $1.18B of net new capital in Q4 2013, opening 438 new positions and adding to 447 existing holdings. Its largest new stake was Bank of America: 11,999,441 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 9.3% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was GSK, an estimated $165M trimmed.
- Arrowstreet Capital's largest Q4 2013 buy was Bank of America: 11,999,441 shares worth $187M.
- Arrowstreet Capital added most to Vodafone in Q4 2013, an estimated $224M increase.
- Arrowstreet Capital's biggest Q4 2013 reduction was GSK, cutting an estimated $165M.
- Arrowstreet Capital fully exited Philip Morris in Q4 2013, selling an estimated $363M.
- Arrowstreet Capital's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2013.
- Arrowstreet Capital opened 438 new positions and closed 319 in Q4 2013.
- Arrowstreet Capital's portfolio value rose 17% quarter-over-quarter to $18.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2013, filed 14 Feb 2014.